Improving Brain Cancer Surgery
For this tumour, surgery is the first step. Surgeons during brain cancer surgery walk the tightrope of removing enough tumour without damaging the brain. Because brain cancer cells extend like thin tendrils several centimetres into the surrounding brain tissue. It is always a challenge for doctors to remove an entire tumour.
Brain cancer is highly recursive with almost 90% patients relapsing back within 6 to 7 months post-surgery (Even after being given chemotherapy and radiation postsurgery). More than 80% of the recurred cancer appears back where the surgery was done. This is where patients usually lose the battle with this tumour. LeadInvent Pharma is developing modality that would complement the current standard of care for hard to treat tumours such as Glioblastoma.